![](https://investorshub.advfn.com/uicon/8777.png?cb=1703671008)
Thursday, July 29, 2021 1:21:07 AM
File Date Form Security Prev
Shares Current
Shares Change
(Percent) Ownership
(Percent) Change
(Percent)
2021-01-15 13G INTRACOASTAL CAPITAL, LLC 3,749,923 4.99
2021-01-15 13G CVI Investments, Inc. 3,800,000 5.30
2021-01-14 13G Empery Asset Management, LP 3,800,000 5.32
More recent filings..
2021-05-13 13F Renaissance Technologies Llc 1.53 3,304,140 570.48 6,972 1,389.74
2021-05-14 13F Vanguard Group Inc 1.53 3,180,565 513.88 6,711 1,264.02
2021-06-01 NP VTSMX - Vanguard Total Stock Market Index Fund Investor Shares [click for advisory] 2,080,920 4,391
2021-05-07 13F BlackRock Inc. 1.80 1,532,282 228,940.66 3,233 323,200.00
2021-06-01 NP VEXMX - Vanguard Extended Market Index Fund Investor Shares [click for advisory] 1,000,089 2,110
2021-05-12 13F Geode Capital Management, Llc 1.53 488,114 442.93 1,029 1,110.59
2021-05-17 13F Cvi Holdings, Llc 432,305 912
2021-07-22 NP FSMAX - Fidelity Extended Market Index Fund [click for advisory] 362,917 1,169
2021-05-19 13F Virtu Financial LLC 1.53 271,937 -1.22 574 119.08
2021-05-17 13F Sabby Management, Llc 242,237 511
2021-05-17 13F Morgan Stanley 1.06 197,733 732,244.44 418
2021-05-12 13F Northern Trust Corp 1.52 145,648 1,258.53 307 2,970.00
2021-05-18 13F Jane Street Group, Llc 94,810 200
2021-07-22 NP FSKAX - Fidelity Total Market Index Fund [click for advisory] 88,019 283
2021-07-19 13F Cutler Group LP 4.20 72,179 63.94 456 395.65
2021-05-13 13F Barclays Plc 1.52 65,694 455.69 139 1,163.64
2021-05-17 13F Goldman Sachs Group Inc 63,770 135
2021-06-01 NP VITNX - Vanguard Institutional Total Stock Market Index Fund Institutional Shares [click for advisory] 60,800 128
2021-07-22 NP FNCMX - Fidelity Nasdaq Composite Index Fund [click for advisory] 60,434 195
2021-07-22 NP FCFMX - Fidelity Series Total Market Index Fund [click for advisory] 58,337 188
2021-05-14 13F Sculptor Capital LP 53,500 113
2021-05-17 13F Capstone Investment Advisors, Llc 51,257 108
2021-05-17 13F Edmond De Rothschild Holding S.a. 50,000 106
2021-05-17 13F Susquehanna International Group, Llp 1.53 49,256 -54.16 104 1.96
2021-04-30 13F Creative Planning 48,666 103
2021-05-17 13F Two Sigma Advisers, Lp 1.52 48,400 348.15 102 920.00
2021-07-26 13F Spire Wealth Management 4.55 48,000 6.67 335 252.63
2021-05-13 13F Bank of New York Mellon Corp 35,927 76
2021-05-21 13F/A Citadel Advisors Llc 1.54 34,070 -22.12 72 71.43
2021-05-04 13F Commonwealth Equity Services, Llc 31,383 66
2021-05-06 13F Meitav Dash Investments Ltd 30,000 63
2021-05-17 13F Bienville Capital Management, LLC 28,379
https://fintel.io/so/us/atos
Recent ATOS News
- Atossa Therapeutics Completes Enrollment of 80mg Pharmacokinetic Run-In Cohort in Phase 2 EVANGELINE Clinical Trial Evaluating (Z)-Endoxifen as a Neoadjuvant Treatment for ER+ / HER2- Breast Cancer • GlobeNewswire Inc. • 07/22/2024 12:30:00 PM
- Atossa Therapeutics Appoints Heather Rees as Chief Financial Officer • GlobeNewswire Inc. • 07/02/2024 08:15:00 PM
- Atossa Therapeutics Announces Updated Protocol for Clinical Trial Evaluating (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO®) in Women with ER+/HER2- Breast Cancer • GlobeNewswire Inc. • 06/28/2024 12:30:00 PM
- Atossa Set to Join Russell 3000® Index Effective June 28, 2024 • GlobeNewswire Inc. • 06/17/2024 12:30:00 PM
- Atossa to Present at the Sidoti Small-Cap Investor Conference • GlobeNewswire Inc. • 06/05/2024 12:30:00 PM
- Atossa Therapeutics Announces Support of Clinical Study Testing New, Artificial Intelligence, Breast Cancer Risk Assessment Model • GlobeNewswire Inc. • 05/28/2024 12:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/24/2024 04:15:32 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/23/2024 01:00:04 PM
- Atossa Therapeutics Announces Last Patient, Last Dose in its Phase 2 Karisma-Endoxifen Clinical Trial • GlobeNewswire Inc. • 05/15/2024 12:30:00 PM
- Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 05/14/2024 08:46:30 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 05/13/2024 08:05:53 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 01:05:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 01:00:12 PM
- Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 05/13/2024 12:50:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/10/2024 01:00:05 PM
- Atossa Therapeutics Announces Support of New Breast Cancer Screening Guidelines • GlobeNewswire Inc. • 05/07/2024 12:30:00 PM
- Atossa Therapeutics Announces Expanded Research Agreement with Weill Cornell Medicine to Further Evaluate Synergy Between Antibody Drug Conjugates (ADCs) and (Z)-Endoxifen • GlobeNewswire Inc. • 04/29/2024 12:30:00 PM
- Atossa Therapeutics and Quantum Leap Healthcare Announce I-SPY 2 Clinical Trial to Evaluate (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO®) in Women with ER+/HER2- Breast Cancer • GlobeNewswire Inc. • 04/15/2024 12:30:00 PM
- Atossa to Participate in Noble Capital Markets Emerging Growth Healthcare Conference • GlobeNewswire Inc. • 04/11/2024 12:30:00 PM
- Atossa Therapeutics Presents Data from 40mg Cohort of Phase 2 EVANGELINE Clinical Trial Showing 100% Disease Control Rate After 24-Weeks of Treatment with (Z)-Endoxifen • GlobeNewswire Inc. • 04/09/2024 03:59:00 PM
- Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 04/01/2024 08:00:00 PM
- Atossa Therapeutics Provides Five-Year (Z)-Endoxifen Treatment Update on FDA-Approved "Expanded Access" Program for a U.S. Breast Cancer Patient • GlobeNewswire Inc. • 03/19/2024 12:30:00 PM
- Atossa Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirements • GlobeNewswire Inc. • 03/18/2024 12:30:00 PM
- Atossa Therapeutics Appoints Breast Cancer Specialist Tessa Cigler, M.D., M.P.H. to its Board of Directors • GlobeNewswire Inc. • 03/12/2024 12:30:00 PM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM